Where does Ankon Medical Technologies (SHANGHAI) Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ankon Medical Technologies (SHANGHAI) Co., Ltd. ranks #7,109 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ankon Medical Technologies (SHANGHAI) Co., Ltd. hold?

Ankon Medical Technologies (SHANGHAI) Co., Ltd. holds 46 US utility patents granted between 2018 and 2025, spanning 22 technology areas.

What is Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s Innovation Score?

Ankon Medical Technologies (SHANGHAI) Co., Ltd. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ankon Medical Technologies (SHANGHAI) Co., Ltd. focus on?

Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 32 patents, ranking #588 of 7,127 assignees active in that subclass. Grants appear in 22 CPC subclasses total.

Is Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s patent grant rate increasing or decreasing?

Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s recent grant velocity is +363% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s patents?

Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s patents average 10.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ankon Medical Technologies (SHANGHAI) Co., Ltd.

Q: How is the Ankon Medical Technologies (SHANGHAI) Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 46 granted patents across 22 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ankon ranks #7,109 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 22 technology areas.

#7,109
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 10.6
avg claims per patent: +363%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7109 · Foreign Corporation #7,109 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,109/49,997
PHOTO-FINISH Ab-kwekersrechten B V
CPC-FOCUS A61B · 22 areas
INNOV-PAR 40.2/100
CLAIMS-PAR 10.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +363% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ab-kwekersrechten B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ankon’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (33%) Velocity 4.0 pts (10%) Breadth 16.6 pts (41%) Claim depth 6.3 pts (16%)

Qualcomm Incorporated · highest

85
[24]7 ai · near

40
Ankon Medical… · this assignee

40
Delta Galil Industries · near

40
J S T MFG · near

40
Medacta International · near

40
3D Lighting… · lowest

7

What this shows Ankon's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ankon?

Each dot is one of Ankon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ankon’s own 10.6 claims/patent is at or below the 10.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Ankon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ankon's grants concentrate

Ankon Medical Technologies (SHANGHAI) Co., Ltd. is a focused PatentsView assignee: 22 CPC subclasses with 69.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (11 grants) versus a trough of 2 in 2018. By volume, Ankon sits between Ab-kwekersrechten B.V. and Aerie Pharmaceuticals, Inc..

Ankon's three-year grant acceleration

From 2019–2021 to 2022–2024, Ankon Medical Technologies (SHANGHAI) Co., Ltd. moved from 27 to 16 grants (0.59x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Ab-kwekersrechten…

46
ACE

46
Amano Enzyme

46
Ampere S

46
Applied Invention

46
Ariel Scientific…

46
Atonarp

46
Aerie Pharmaceuti…

46
Ankon Medical (Sh… ◀

46

What this shows Ankon holds 46 patents at rank #7,109, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ankon

By rank, the assignees closest to #7,109 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Ankon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ankon, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Ankon ranks #588 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

[24]7.ai, Inc. 40 J.S.T. MFG. Co., Ltd. 40 Medacta International SA 40 Delta Galil Industries Ltd. 40

Ankon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Ankon Medical Technologies (SHANGHAI) Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	4.3%
2019	6	13.0%
2020	11	23.9%
2021	10	21.7%
2022	5	10.9%
2023	9	19.6%
2024	2	4.3%
2025partial year	1	2.2%

Which technologies does Ankon Medical Technologies (SHANGHAI) Co., Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 32

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 4

G02B - Optical Elements, Systems OR Apparatus 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

H04N - Pictorial Communication, e.g. Television 2

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 1

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

G03F - Photomechanical Production OF Textured OR Patterned Surfaces, e.g. FOR Printing, FOR Processing OF Semiconductor DEVICES; Materials THEREFOR; Originals THEREFOR; Apparatus Specially Adapted THEREFOR; 1

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

Top 15 of 22 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s patent record in context - here's where to go next.

Ankon Medical Technologies (SHANGHAI) Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 69.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #7,109 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ankon Medical Technologies (SHANGHAI) Co., Ltd. against Ab-kwekersrechten B.V., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.